Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Podcasts

Back to Item »

ROUNDTABLE DISCUSSION ON BIOTECH/PHARMA DEALS

- Martina Molsbergen, VP, Business Development, Crucell; Barbara Yanni, Chief Licensing Officer, Merck & Co.; David Colpman, Senior VP, Business Development, Shire Pharmaceuticals; and Joern-Peter Halle, Head, Early-Stage Licensing, Merck Serono, a division of Merck KGaA

Forward this item to a colleague:
Your name
Your email
(Separate multiple addresses by commas)
 
Colleague's email
(Separate multiple addresses by commas)
 
Personal Message
(optional)
 
 
 

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll